Skip to main content
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
2.653
+0.073 (2.85%)
Oct 3, 2024, 4:00 PM EDT - Market closed

Marker Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Marker Therapeutics stock has a target of 11, which predicts an increase of 314.56% from the current stock price of 2.65.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change +314.56% +314.56% +314.56% +314.56%
* Price targets were last updated on Apr 30, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for MRKR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Aydin Huseynov
Ladenburg Thalmann
 Ladenburg Thalmann
Strong Buy
Initiates
$11
 Strong Buy Initiates $11 +314.56% Apr 30, 2024
Tony Butler
Roth Capital
 Roth Capital
Hold
Downgrades
$30 → $10
 Hold Downgrades $30 → $10 +276.87% Feb 17, 2022
Joseph Catanzaro
Piper Sandler
 Piper Sandler
Buy
Initiates
$60
 Buy Initiates $60 +2,161.25% Mar 25, 2021
Kristen Kluska
Cantor Fitzgerald
 Cantor Fitzgerald
Buy
Initiates
$60
 Buy Initiates $60 +2,161.25% Mar 19, 2021
Kristen Kluska
Cantor Fitzgerald
 Cantor Fitzgerald
Buy
Initiates
$60
 Buy Initiates $60 +2,161.25% Mar 18, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
4.50M
from 3.31M
Increased by 35.94%
Revenue Next Year
n/a
from 4.50M
EPS This Year
-1.46
from -0.94
EPS Next Year
-1.49
from -1.46
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
213.19K466.79K1.24M3.51M3.31M4.50M--
Revenue Growth
3.50%118.95%166.01%182.96%-5.76%35.94%--
EPS
-4.70-6.10-5.47-3.59-0.94-1.46-1.49-1.33
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 4.6M n/a n/a
Avg 4.5M n/a n/a
Low 4.3M n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
40.0%
- -
Avg
35.9%
- -
Low
30.6%
- -

EPS Forecast

EPS 2024202520262027
High -1.50 -1.53 -1.37
Avg -1.46 -1.49 -1.33
Low -1.40 -1.43 -1.27

EPS Growth

EPS Growth 2024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.